mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.4 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |